Bird Flu Research OK to Publish

Scientific panel gives approval to papers on deadly virus
By Mark Russell,  Newser Staff
Posted Mar 31, 2012 6:38 AM CDT
Bird Flu Research OK to Publish
In this 2011 photo, a worker inspects labels on vials containing H5N1 flu vaccine during production at the Beijing-based drug maker Sinovac Biotech Ltd. in Beijing.   (AP Photo/Andy Wong)

(Newser) – Some controversial research on bird flu is safe to publish after all, reports the New York Times. A panel of scientists yesterday reversed its December decision and concluded that two revised papers on the H5N1 virus were good to go. The board created controversy last year when it asked two scientific journals, for the first time, to keep key details under wraps. The decision clears the way for Science and Nature to publish the papers soon, notes AP.

story continues below

Although H5N1 is deadly in humans, it usually cannot be contracted by people. Two research teams modified the flu strain to make it more easily contagious, leading to fears the technique could be used by terrorists. However, the research “did not appear to provide information that would immediately enable misuse of the research in ways that would endanger public health or national security," said the National Science Advisory Board for Biosecurity. Not everyone is happy with the decision, though. “This work should never have been performed," said one bioweapons expert. (Read more H5N1 stories.)

We use cookies. By Clicking "OK" or any content on this site, you agree to allow cookies to be placed. Read more in our privacy policy.
Get the news faster.
Tap to install our app.
Install the Newser News app
in two easy steps:
1. Tap in your navigation bar.
2. Tap to Add to Home Screen.